throbber
'
`
`379-380 B riefReviews
`J. S. Gram*usrrr."H
`
`Lalb
`
`Or1'ginal Articles
`381-384 IHFLIIEHBE [IF THE IIEFEHEHIIE GAS IIF PABAMHBHETIG
`IJHTIIEIII III‘IM.TZEH$ [IN NITHIIHEII IIIIIIIIEIITHHTIIIIIS
`IIIIIIIIIII IIIJISEII-IIIHIIIIIT MIESTHESIII
`
`'
`
`jmu F. ./I. He1:d:'frIe.\', MD, A.I:rJ’.I‘r'/i.]. mmZH.Ink'r.', MUD,
`PHD, rmd Andre M. de fwl/o._‘,C M D
`
`
`
`_
`
`‘
`
`385—391 HIIHILHBIIITT [IF HEIIEIHIIS IN MI IIIITPHTIEIIT
`PIIEIIIIESTHETIII EWIIJIIITIIIII IELIIIIC
`CorJo.u L. Cfllby, IND, a.'ufI'VfHrem K. S(:":Im1'J_ PHD
`
`393402 M’ WHflEIIIII.I.IIITIIIII IIF I HLIIHEII LIJIIP IITIIIIITIIIIIIIII
`STIIHTEIIT EIIII IIIIIIIIIEII PHHHLTSIS
`
`Deepafc Rmm'n'er:'sJ'nm, MS, Khosrow Be!'.=!JeI'.tm.-1', PhD, PE,
`Kevin Kfeirr, M D, _)‘.L_*[',?}'ey Mo:'e;':rr.':', J‘:/IS,
`14/03’ H’. um: Mnhzm":.-r, Ph D, PE. Rn.":.«'r.' C. E1'm'hm'.'. PhD,
`and Mfcfmci Doflnr, M S
`
`4()3—4I2 HEFIEIITINBE I’I.II.5E IIHIIflETIIT— PRINCIPLES MIII
`IIHSTETHIB flI'PI.IIIIITIIIII III THE ZIIIIIIIH 3T3TEHI
`Vofker Kfiwnflq, Renate Hath, r.-ud /lhberr Hm}:
`
`_—T 413-420 HIIIIHHRCT IIF HULIIHE MEISIIHEMENTS III II'|EI:Hfl|'1III:IIlI.T
`Volume 14 Number 6 Asggzrst 1998
`HEtI‘flTH1lI"Il1IIElllI'I‘t'EE“:1'lIl|IJ'I'slIFl:ll||‘|M£Bl:lAl.l]E|llBES
`Km’ Rosier, Berfmm Fofrzfk, Roland R. I»!/am-r, and
`G:-rd Schumh‘.er.-':
`
`421-424 MI EIIIII.IITIIIIIIlHT SIIIIITIIIN TU MIESTHESIH IIIJTEIHIIITEIJ
`IIEITIIHD KEEPING
`
`AIM: A. Bfrl'eeI', P.-':D, join:
`Prmf Poppers, M’ D
`
`'
`
`Cage, MD, and
`
`425—43'.f EW-II.I.|flTIII|'1| IIF A PITIJT TYPE SPIHIIIIIETEH IH HEIIHIIW
`UIWIIEH IHIITIIIIES
`
`Soren .'§oma'e:_'qr:rrr'rf. MD, Sig:r1'b:':g:rI‘ K&ms:m. M D,
`Stqfnti Lm1r."iH, MT), and Ola Sn-nqm'.<.', MD
`
`433-459 IIETEIITIIIH [IF |.IINIi IHJIIHT WITH GIIHIIEHTIIINIIL AND
`IIEI.IIIfll HETWIIHK-HIISEII IIHMJISI5 [IF IIIIIITIHIIIIUS IIIITH
`jrrkkn Ri1's£r'He.u, MD, mm‘ fI.a'mrn’c:'o A. Iron, MD
`
`Algorithm
`44.’-446 II HEM.-TIME IILIIIIHITHTII TII IIIIPHIWE THE HESI'I]H3E TIME
`III: I BLIIIIBHL IIIIILTIIIIIS HHIILTSEH
`Lnwdy Wong, MSc, Run’: Hrum’:'rou. MB, CF18,
`Eifrm Pm'ayIwa, PIID, (Hid C:':'m' Hm‘m, D. Phi!
`
`Boole Review
`
`447 L E. HENSIJH MID H. 3. LEE [EDS]: SIHIIIUITIIHS IN
`IIHESTHESIDLIJIIY EIIIIIIIITIIIN
`Rr'¢'Imrd ."'n'urr.I‘s
`
`449-450 INFUHMATIUHEHH IIIIHTBIIIIITIIIIS
`
`: 1:
`
`\.\.r;.--‘.!;
`
`J U L 3 U 1999
`
`4-
`Apple Inc.
`’“’“°”
`. 8 989 830
`=
`=
`
`#7
`
`OGDEN JCMOEH
`lSSN1387—1307
`
`I
`
`.
`.
`U 5 Patent N0
`
`4
`I
`I
`
`KLIIWEII ncnnswnc PIIBUSIIEIIS
`
`‘s'5:'§'I’:'u?u‘a&'3I':'n‘a'é“;In'u$'rTe'I:'E.n'i'uI'E3E5“" ‘'’°'‘"
`Ill AIIAESTIIESIA Ann INTENSIVE onus, man or
`41
`
`I
`
`Apple Inc.
`APL1014
`U.S. Patent No. 8,989,830
`
`

`

`
`
`JOURNAL [IF GLINIIIAL NIIJNITIIBING
`AND BIIMPIITINII
`
`E|FFIllllll. Jfllllllllll. [IF THE ElIlllJl’Ell|"l SIJSIETY Fllll lllJ|lIl'Il'l'lll[l Mill] TElIHl'lllI.IIll‘l' Ill llll|llESTIlE8lA Mill! IHTEHSIVE BIIHE IESIITAIIII
`Mlll [IF THE SIIIIIETT Fllll TEl3HllIJl.lIlliY Ill MIESTIIESIA [STll]
`
`Volume 14 Number6 August 1998
`
`WEST?” Hon -
`
`.5 Y
`
`Harvey L: Edrnouds, MD
`john H. Eichhorn, Ml)
`Tam my Y. Euliano, MD
`M. Fisher, MD
`A. Dean Forbes
`Wolfgang Friesdorf, MD
`Yasuhiro Fukui, PhD
`Leslie Gecldes. PhD
`Nikolaus Gravenstein, MD
`A. Gerson Greenburg, MD, PhD
`G. I-Iedenstierna, MD
`Wolfgang Heinrichs, MD
`R. C. G. Gallandat I-Iuet, MD
`
`
`
`TIIE PIIIIENT Jllll lllilfils
`flalui-riIai’ing rmrl Cmripnffiig,
`lHrei'mm'o.Iml _]orrrn.1l qf Clinirnl
`founded by Omar Prakash in 1984; Reed Gardner, senior-
`editor; and the
`jarrriral qf Clirricnl Mrmfrerfng, Founded in 1935 by N.Ty
`Smith, Allen K. Ream, and J. S. Gravenstein.
`'
`
`
`EIIITUIIS
`
`Jeffrey M. Feldmau, MD
`Allegheny University Hospitals, MCI’
`Dept. oFAnesthesiology
`3300 Henry Avenue
`Philadelphia, PA19129, U.S.A.
`E—niail: Fcld1na1i]@aL1hs.cd1t
`
`J. S. Gravenstein, MD, Coordinating Editor
`UF,lCollege of Medicine
`Dept. offlnesthesiology
`P.O. Box 100254
`Gainesville, FL 32610. U.S.A.
`E—n1ail: jgravens@anest2.anest.ufi.edu
`
`Ilkka Kalli, MD, PhD
`City Maternity Hospital
`Dept. ofAnae-sthesiology
`P.O. Box 61
`
`FIN-00971 Helsinki, Finland
`E-mail:
`i1kka.lcalli@iki.Fi
`
`Publisher
`Kluwcr Academic Publishers
`l’.O. Box 990
`3300 AZ Dordrecl1t,The Netherlands
`
`E—mail: Locs.Wils@\vkap.nl
`
`EIIl'I'flIIIll.l. Illflflll
`Paul G. Barash, MD
`' Gerard Bashcin, MD, PhD
`Charlotte Bell, MD
`Jan E.W. Beneken, PhD
`J. A. Blom, PhD
`J. G. Bovill, MD, PhD
`Peter Carsten sen
`Williarii P. Coleman, PhD
`Jeffrey B. Cooper, PhD
`john Doyle, MD
`Ronald Dueek, MD
`Peter C. Duke, MD
`
`
`
`All rights reserved ISSN I387-1307
`
`© 1998 Kluwet Academic Pu blishcrs
`No part of the material protected by this copyright notice may be
`reproduced or utilised in any Form or by any tueans. electronic or
`mechanical. including photocopying. recording or by any informa-
`tinu storage and retrieval system. without written permission from
`the copyright owner.
`
`Printed in the Netherlands
`
`Primed on arid-fire pa,-irr
`
`J U
`
`L
`
`3 U
`,
`_-5 L,
`‘mull Cl'j-'=.--'i
`.
`.'
`5"“ HFBHLAM: nu"-5.mu.;-.uri, Wlh-:1 R
`
`Kazuyuki lkeda, MD
`Villejantti, MD
`Gavin N. C. Kenny, MD
`Samsun Lampotang, PhD
`J. W. R. Mclntyre, MD
`James H. Philip, MD
`Michael L. Quinn, PhD
`Ptadcep Ramaaya, MD
`Ira]. Rampil, MD
`Gunter Rau, MD
`Michael F. Roizen. MD
`
`].—A. Roniaud, MD
`Williain 13. Runciman, MD
`Keith Ruskin, MD
`David A. Sainsbury, MD
`l-I. Schillings, MD
`john W. Severinghaus, MD
`M. Michael Shabot, MD
`Dean Forrest Sittig, PhD
`Bradley E. Smith, MD
`Richard Teplick. MD
`Kevin I{.Tren1per, MD
`Jorge Urzua, MD, PhD
`Karel H.Wesseli11g, PhD
`Dwayne Westensl-row. PhD
`j. C. Wyatt. PhD
`
`
`
`llllllllli I4. ll ISSIIES. 1998
`Issues include:
`Brief Reviews, Editorials. Clinical Articles. Research Ar-
`ticles, Educational Articles, Book Reviews, Correspondence,
`Selections fi‘o1n the Anesthesia Patient Safety Foundation
`Newsletter.
`
`Klurverfltademic Pm'u'i’sliers, Dordrecht. Boston. London
`
`Kluwer Academic Publishers Online
`Visit our website at http:Hwww.wkap.11l
`
`The jnirrtml of Cliiiirnl rlrltltiitnriug mm’ Coirtprrriiig is indexed in lmlr-.\'
`Mr-tlirrrs, Cm'rt'nr Cmirerrrs/Clirtiml .r'l*lt'd'ia'ne, E.\‘reJ';,mi rlrlerlicrr, Currrmr
`z‘lwnrt’m's5 in Biological Srienres, and the Binriiediral Erigftieeriirg Cftariori
`ludt'.\'. and is indexed_»‘abstracted in Engine:-rin_q Iimle.\', Srirrrce Cfmtimi
`lmile.\', Expnrrrletl Rrsenrrl: Alert, Merlin: Dntmileiimrirlri Stwicr.
`
`II
`
`II
`
`

`

`| This material may be protected by Copyright law [Title 1? us. Code]
`
`403
`
`BEFLEBTANBE PULSE llX|METflY— PRINCIPLES Alllll
`OBSTETBIS APPLIIIATIUN IN THE Zlllllflll SYSTEM
`
`Kiinig V. lluirh R, Huch A. Reflectiince pulse o_\'i1nel'ry — principles
`and obstetric application in the 7.uriCl1 system.
`J Clin Monit 1998: I4: -103--H2
`
`I/ol!'cei' Kilt-rig, Rcna.te Hitch, and /‘lll){.’l"l Hut.-'i
`
`HIISTINWT. Transmissioii and reflectance are the two main
`
`modes ofpulse oximetry. In obstetrics, due to the absence ofn
`trzlnsilliniiinable feta] part For transinission oximetry. the only
`Feasible option is the 1'eflcct;1ncC mode, in which sensor and
`detector are located on the same surface of the body part.
`However, none of the teflectance pulse oxiineters developed
`For intraptirturn use are fully szltisftictiny, :15 lllCllC:1|I€Cl by the
`Fact that none have entered routine use. We have designed,
`developed, constructed and tested a reflectaiicc pulse oximeter
`with the possibility to adjust the electronic circuits and signal
`processing in order to determine the effects ofvarious paramu
`eters on signal amplitude and wave—for1r1 and to optimize the
`sensitivity and spatial arrangement ofthe optical elements.
`Following an explamtioii of the principles of reflectance
`pulse oximetry, we report our experience with the design,
`development, construction and field-testing of an in~hoi.isc
`reflectance pulse oximetry system for obstetric application.
`
`KEY WIJHBS. O.\'\_,-‘gen saturation, refiectance pulse oximetry,
`intrapartum fetal inonitoring.
`
`lN'|'|iI]lJ|lBTl{I|l|
`
`Pulse oximetry is the combination of spectrophotome-
`try and plethysmography. It permits rapid noninvasive
`1'nez1surement of arterial oxygen saturation with the
`added advantages of simple sensor application and direct
`nieasurenient, requiring neither calibration nor pre-
`adjustinent. Pulse oxinietcrs are thus in vvidesprezid and
`Fast—increasing use, e.g. in intensive care, anesthetics and
`neonatology [1]. All these applications employ “trans-
`mission” pulse oximetry, so called because the light
`used to determine blood oxygen saturation is “trans-
`mitted" from :1 light emitter on one side of the body
`part to :1 light receiver on the other side; suitable sites
`are the fingers in adults or hands and feet in neonates or
`children, which are said to be “transilluminated.”
`
`In obstetrics, fetal oxygen status during labor is a
`crucial pzitanictcr. However, no transilluminable Fetal
`part is available. The only option in this case is reflec-
`tance oximetry [2], using :1 sensor with its light emis~
`sion and detection elements on the same surface of
`
`the body part. Various types of such a reflcctance pulse
`oxinietcr have been developed for intrapalrtuni use at
`various locations. I-Iowever, for :1 wide variety OF‘I'CZlS0l"1S,
`
`all are still experimental and not in full routine use [3—7].
`Basically a refiectancc measurement can be achieved
`using planar sensors — which can be produced,
`for
`example. by modifying conventional traiistnission sen-
`sors — and :1 sensitive modern pulse oxinicter. Hoivever,
`
`From the l’erin:It:il Pliysiology Rcsentcli Departnient. Departinent
`of Obstetrics, Zurich University Hospital. CH—8{I‘)I Zurich. Switzer-
`land.
`
`Received Nov I3, 1997, and in revised Formjun 23,
`for publication Aug 4, I998.
`
`l‘J‘)8, Accepted
`
`l-’l.'l'll'I4'lE£ll l’hysiology Re-
`Address c01'i'esp0l1Llei1cC to V0llCL‘I' Kfiliig,
`search Departnient. Department of 0bstet1'i:.‘s. Zurich University
`Hospital. Cl-l—R0‘Jl Zurich. Sivitzerlantl.
`E-mail:
`\'l£gQlf_._fl1l(.llSZ.Cl]
`
`_,I'unriml qfCli:n'mu' Mmiimr:'iIg rmrl Cniiipnrirng 14: -"H13--I I2. 1998.
`CC‘ I998 Klnnrer/lrmlrmft Pnlilr'sl'n'i's. Print:-n‘ in the !\7erl'ir'n'niiri's_
`
`403
`
`

`

`404 jom':MiofC.I'niimI'M'airf.'ui'irn3aiid Cumpnfing I/m')'4 N06 /lugusrI998
`
`em,
`
`d(t)
`
`absorption coefficient of reduced hemoglobin
`(function of wavelength)
`time function of mean pulsatile change in artery
`thickness, with amplitude d : d(diastole) —
`d(systole)
`
`Measurement may be impaired by light transmitted
`directly from the light source to the receiver or light
`which does not pass through arterially perfused tissue.
`Ifthis “direct light“ 1,1,, is taken into account, Equation
`(1) changes to:
`
`I“) = [tissue ' exP(_(SO2 ' EHb0+
`(1 ‘ 502) '€Hbl
`‘ d(t)) + Idir
`
`(M)
`
`where
`
`Ilissut : Iii
`
`'9xP(“5tissi1i.- ' 5)
`
`Since the pulsatile component of the absorption is at
`most a few percent, i.e. the exponent of the second e
`function in Equation ('1) is very small, we can use the
`approximation:
`
`exp(x) = l + x
`
`for
`
`<<l
`
`to obtain the very close approximation:
`
`I(t) =
`
`[tissue '
`
`_
`
`' EHIIO +
`
`_
`
`' EHI) '
`
`+ Idir
`
`(lb)
`
`This light intensity is measured in the photodiodes and
`can be broken down electronically into two compo-
`nents, a time-independent signal
`
`DC = Itissuc + Idir
`
`with amplitude equal to the value ofthis signal
`
`such instruments come with a “black—box" 1nicroproces—
`sor—controlled mode ofoperation making constructional
`adjustments to the electronic circuits and signal process-
`ing virtually impossible. As a result, it becomes difficult
`to determine the effect of various parameters on signal
`amplitude and wave-form, optimize sensor sensitivity to
`light intensity and the arrangement of the optical ele-
`ments, and hence assess the dependence ofarterial oxygen
`saturation measurement on key physical, technical and
`above all physiological variables. This was the aim
`driving our decision to design, develop and construct
`in—house a system dedicated to obstetric applications.
`Following a brief review of the principles of pulse
`oximetry, we report our experience with the develop-
`ment of the new device,
`together with some field-
`testing results.
`
`
`
`PBINBIPLES [IF PIlI.SEOXIl'i1ET|IY
`
`Sig:-rel recording
`
`Light is absorbed on passing through matter. The de-
`gree of absorption depends on the nature of the trans-
`illuminated material and the wavelength of the light
`employed. All optical techniques for determining arte-
`rial oxygen saturation use the marked difference in the
`absorption of red light between oxygenated and re-
`duced hemoglobin.
`The absorption of light passing through bone or
`nonpulsatile tissue is constant over time. Oxygenated
`and reduced hemoglobin in the arterial vascular bed, on
`the other hand, cause changes in absorption timed by
`the heart rate due to the pulsatile variation in artery
`thickness. The total intensity of the light after passing
`through tissue ca11 be measured, for example, as the
`photocurrent I(t) ofa photodiode, and is obtained from
`the Lambert—Beer absorption law as:
`
`I(t) = In ‘ exp(—E,;,,m. - s) - exp{—(SO3 - EH50 +
`(1 — so?) - Enbl « dun
`
`7|
`"’
`
`dc E DC = Itissuc + Idir
`
`where
`
`intensity ofincidcnt light
`In
`I-:,i_,_,,,._. mean absorption coefficient of tissue (function of
`wavelength)
`mean thickness oftransilluminated tissue
`
`5
`
`SO;
`
`oxygen saturation to be determined (3 I-IbO]
`(HbO + Hb), i.e. ratio of oxygenated hemoglo-
`bin concentration to sum of oxygenated and
`reduced hemoglobin concentrations)
`t-:H;,.;) absorption coefficient of oxygenated hemoglobin
`(function of wavelength)
`
`and a signal which varies in time with the pulsatile
`change in artery thickness
`AiC = ltimu.
`- (S03 - E|.u,o + (l — S03) '5H[,) ' d(t)
`
`(4)
`
`with amplitude
`
`ac = I(diastole] — I(systolc) =
`
`Itissue '
`
`'5Hl:0 + (I — S02) ' "5-Hls)
`
`‘ d-
`
`Thc ratio between the ac and dc amplitudes is then
`
`

`

`Kiiiiig or al: The ZIrn'r."r Obsnerrfr Rtjfiermiire Pulse ().\'lHl£'l(’l'
`
`405
`
`r : acid‘: = (llissiicxulissiic + I(|ir))'
`(502 ' €Hbo + ('1 ' 302) ‘Final ‘ d-
`
`6
`
`}
`
`(
`
`this ratio r is
`In the case that “direct light” 1.1,, = 0,
`independent of the incident light intensity In and ofthe
`absorption in the nonpiilsating tissue value ltism:
`
`However, despite various theoretical models [9, l0],
`the scatter coefficients of the various tissue types are
`not known with sufficient accuracy to permit exact
`calculation. Expcrinieiital calibration thus Iias to be
`performed by directly comparing the pulse oxinietcr
`readings with arterial blood sample values.
`
`r = ac/dc =
`(503 - EH50 + (l - S02) - E31,) - d
`
`for Edi, = 0.
`
`(6a)
`
`'Ii'ansuiissi'on pi-Ilse om‘:-iieti'y
`
`then dependent only on the oxygen
`This ratio r is
`saturation S0; to be determined, the known absorption
`coeflicients EH50 and EH5, and the mean pulsatile change
`d in the thickness of the arterial vessels in the trans-
`
`illuniinated region.
`To eliminate this dependence on d, the measurement
`is performed at two wavelengths with maximally dif-
`fering absorption coeflicients. On the assumption that
`the d values are the same for both wavelengths, we
`obtain a variable
`
`R = rm;/ri, = (ac/dclmi/(ac/dc)ir
`
`= (502 ' 5HbO + (1 F 5O2l '5Hbln-.i/
`(502 ' 5HbO + (1 — Sozl '5Hblir
`
`(7)
`
`7
`( 3)
`
`The optical elements are located on opposite sides ofa
`body part. The sensors are applied mainly to the fingers
`and toes. Ears and nose are used only rarely due to poor
`perfusion. In neonates the sensor is applied around the
`hand or foot. This arrangement largely ensures that the
`optical paths are the same for both wavelengths. Never-
`theless, incorrect sensor attachnient can give spurious
`results, e.g. if some of the transmitted light reaches the
`receiving diodes around the outside ofa finger as “direct
`light.”
`Signal magnitudes are an important determinant of
`measurement accuracy: in normal fingertips, the ratio
`ofthe signal due to absorption in pulsating blood (ac)
`to the signal due to absorption in total tissue (dc), r =
`acfdc, is 0.02—0.05.
`
`from which the unknown S02 is readily calculated
`without knowing the incident light intensity or tissue
`thicknesses.
`
`Calculation assumes the following physical prerequi-
`sites:
`
`0 No light must be measured that has not passed
`through the pulsatile vascular bed e.g. light passing
`directly from light source to receiver (ldir).
`0 The pulsatile changes in artery thickness must be the
`same for both wavelengths,
`i.e. both wavelengths
`must transilluminate the same tissue region.
`0 Valid measurement assumes that the pulsatile signal
`originates only from varying absorption by arterial
`oxygenated and reduced hemoglobin. The results are
`falsified by other causes of pulsatile changes in optical
`thickness, e.g. hemoglobin derivatives, circulating
`pigments, pulsatile changes in thickness produced
`mechanically in nonarterially perfused tissue by car~
`diac action. and, above all, venous pulsation.
`0 To simplify description ofthe principle behind meas-
`urement and its limitations,
`the Lanibert—Beer law
`was assumed valid for the passage of light through
`tissue. However, as light is not only absorbed in tissue
`but also scattered, the law is of limited applicability
`[8]. The exact absorption coefficients must be cor-
`rected by taking the scattering effect into account.
`
`Reflerrm-ice pulse oxii-iierry
`
`In this method the light backscattered in the body is
`used to determine oxygen saturation. The optical ele-
`ments are thus located on the same plane on the same
`body surface. Reflection originates from nonhomo—
`geneity in the optical path, i.e. at the interfaces between
`materials with different refractive iiidices. This means
`that on physiological grounds, strong reflections can be
`expected on the entry of light into bone. The traiis—
`illuminated tissue must also be well perfused to obtain
`as strong a signal as possible. Not all body parts are as
`well perfused as the fingers or hands, but an ac/dc ratio
`of 0.00l—0.005 can be achieved on the forehead. Perfu-
`sion is also good over the sternum. One method of
`signal enhancement is to heat the measurement site to
`induce hyperperfusion, which can safely be performed
`up to 42 °C. A rubefacient, e.g. nicotinic acid (Rubri-
`ment), can also be applied to the measurement site.
`The principal physical limitations are the following:
`
`o The sensor design rriust eliminate “direct light,” i.e.
`light passing directly from the light sources to the
`photodiodes or that is only scattered in the outer part
`ofthe skin.
`
`0 The measured AC signals are some 10 times weaker
`
`

`

`406 jmrnml ofCh'niml Moiiftnrirtg and Coiiipiiriiig Val 14 Na 6 .r‘ll'l'gI'I$I I998
`
`than in the transmission method. The conditions
`
`governing the heating of the light—emitring diodes
`(LED) limit
`the potential for producing stronger
`signals by increasing the incident light intensity: not
`only can high uncont1'olled temperatures damage
`tissue at the measurement site, but the wavelength
`of the emitted light changes as the LEDs become
`warmer. For this reason the photodiode area must be
`as large as possible.
`0 As in the transmission mode, the principle of meas-
`urement is the determination of absorption, except
`that this now refers to incoming reflected light. The
`light path is less well defined than in transmission
`mode, and thus may differ between the two wave-
`lengths. The effective absorption coefficients of the
`calibration inserted in the Lambert-Beer law must be
`
`checked and if necessary corrected by comparison
`with photometrically measured arterial blood values.
`
`
`
`neonatal head. Experimentation led to the choice ofa
`vacuum system using sensors cast from silicone rub-
`ber, with a suction groove for fixation, a guard ring
`against direct light, and a connector for a suction
`pump. The photoelectric components are identical in
`both types ofsensor.
`I Some metal sensors were fitted with a resistance-wire
`
`heating coil of maximal output 200 mW' to induce
`local hyperemia. The temperature was monitored by
`a negative temperature coefficient (NTC) resistor in-
`corporated in the sensor unit.
`
`Numerous types of sensor meeting the above require-
`ments were built. A sensor used for intrapartum meas-
`urements — cast from silicone rubber with suction
`
`channel and pump connection — is shown in cross-
`section in Figure 1. It is attached to the fetal head with a '
`vacuum of approximately 100 mbar.
`
`TIIE ZIIIIIBH IIEFLEIITANIIE PIILSE IIKIIIIETEB
`
`Elecrroiiics
`
`Sensors
`
`In constructing planar reflection sensors, i.e. sensors in
`which the photoelectric emitting and receiving elements
`lie next to each other in virtually the same plane, special
`attention was paid to the following points (Figure 1).
`
`0 For maximal independence from local tissue differ-
`ences, a radially—symrnetric pattern was selected for
`the photoelements. The light source ~ a chip with
`two LED5 for the wavelengths red = 660 inn and
`infrared = 920 nm — was placed in the center of the
`sensor and surrounded by a radial photodiode array
`for detecting the reflected light. To obtain a good
`signal at minimal
`light intensity,
`the area of the
`photodiodes had to be as large as possible. After some
`preliminary experiments,
`six BX33 pliotodiodes
`(Siemens) were used with a mean radius of 17 mm.
`Their connections are led outwards individually, so
`that the sensor as a whole remains operational if a
`wire breaks or an individual diode is lost. This arrange-
`ment gives an external sensor diameter of22 mm.
`o A guard ring around the LEDS acts as a barrier to
`"direct light." The sensor must also fit snugly to the
`skin to minimize the risk of ambient light reaching
`the photodiodes.
`9 Unlike with transmission sensors, fixation to the
`
`measurement site can pose problems. Aluniinuni sen-
`sor units are readily fixed with double—sided adhesive
`ECG rings. However,
`these rigid sensor heads are
`unsuited to the small radii of curvature of the fetal]
`
`Initially, we decided to separate signal processing in the
`analog part before the analogldigital converter (ADC),
`including signal amplification, filtering, and separation
`into DC and AC signals, all handled electronically ; the
`post—ADC digital part was handled by software which
`input the data, averaged and evaluated amplitudes, cal-—
`culated saturation and heart rate, and produced a some-
`what complicated screen display. Now, using modern
`techniques, we have a system in preparation in which a
`fast separate microprocessor unit handles most signal
`processing and digital filtering tasks.
`Figure 2 shows the block diagram of the current
`apparatus with the following individual units:
`
`0 Time control ofmeasurernent
`
`From a rectified mains power supply signal (100 Hz),
`a phase—locked loop (PLL) — connected as a frequency
`multiplier — generates a square—wave signal of 64
`kHz. Coupling to the line frequency eliminates data
`acquisition faults due to interferences with the line
`frequency. The 64 kHz from the PLL clock drives a
`' 7-bit counter that addresses an EPROIVI giving a data
`cycle ofl kHz, 64 pulses long. The output pulses of
`the EPROM control
`the entire sequence of light
`emission, signal acquisition and signal processing.
`0 LED drive
`
`Theoppositely poled red and infrared LEDs are
`located in the output circuit of a current—stabilized
`push—pull output stage. They are triggered by digital
`signals from the control unit via analog switches at
`the 1 kHz sampling rate in the equally spaced se-
`
`

`

`K¢'i::{g_r N r.-I: Thr Znrfrh ()l'm‘n*rir Rqfl:'r.'rrm‘r' Prrkr ('J.\':':m=:c*.-‘
`
`407
`
`
`
`
`
`.=
`
`‘EH | El
`
`
`
`@ Vacuum-tube
`G Photodiodes
`@ SignaI—cab|e
`@ Red and Infrared LED's
`
`6) Light barrier
`Ft}. 1. Cwss-serlimi !J'n'on_Qi’I :1 sr'h’rnnr- rnhbuw rqflccrfon scnsorfor iurmpamrm n:casm'wm'u.' ¢y"o.\*}*ge.I: sann'rm'on.
`
`

`

`408 jairrriai t5fCl'ii:ftau' Moiiitoriitg mm‘ Coiirptirii-ig V0114 N06 August 1998
`
`
`
`Computer
`
`
`
`
`
`Pre-
`
`Amplifier
`
`Vacuum
`
`Pump
`and
`
`
`
`Control
`
`
`
`
`
`
`Ext. Device
`
`
` Oseillatorfcontrol Unit
`
`(HP, Nellcor)
`
`
`Fig. 2. Stireiimtic represeiitnfioii ofriieasureincm eietrrairirs.
`
`quence: infrared—dark-red—-dark (overall length: 1 ms).
`Light intensity is determined by the amplitude of the
`signal driving this output stage. lnput signal intensity
`can be selected in two ways:
`* Manually: The red and infrared LED intensities
`can be manually adjusted independently using two
`potentiometers (Helipot). This permits the use of
`any desired light intensity within the limits stipu-
`lated for test and research purposes.
`— Automatically: DC voltage as the input signal
`controls the LEDS so that the DC voltages at the
`computer input for both wavelengths are 2.0 :i: 0.5
`V. Outside this range the control circuit changes
`the LED currents to reset the DC voltages to 2.0 V.
`This setting is used for normal clinical applications.
`To prevent skin damage from overheating even in
`the event of electronic component failure, maximal
`LED intensity is limited by an electronic circuit.
`Input amplifier and sample—and—hold stages
`Using operational amplifiers the photocurrent sup-
`plied by the photodiodes is converted to.a voltage
`and then amplified. Six switch positions permit am-
`plifications of 50 mV/nA to 5 V]nA. Afterwards,
`three sample—and—hold (S35!-I)
`stages — switched
`by the corresponding signals from the control stage -
`resolve the signals into the three components infra-
`red, red and dark. The dark currents are then sub-
`
`tracted from the red and infrared signals in a subtrac-
`tion stage which also eliminates small ambient light
`components that may have reached the photodiodes.
`
`o Filters
`
`Using low—pass filters the discrete—tirne signals at the
`S&I-I output are reconverted to continuous—time sig-
`nals and trimmed of high—frequency components
`using eighth-order Bessel
`filters with a cut—off
`frequency of 7 Hz. The DC components are then
`separated using a low—pass filter with a cut—off fre—
`quency ofO.1 1-12. The AC components are passed to a
`further Bessel high-pass 0.7 Hz filter for separation of
`slow motion artifacts, and then to a 40-fold amplifi-
`cation stage. The four signals DCi,, DC,,d, ACi, and
`AC,,d are thus available at the output. As oxygen
`saturation is calculated from the ratios (ac/dc);, and
`(ac/dc),cd, it was essential to ensure by careful com-
`ponent selection that the amplifications for the am-
`plification and separation stages were as near as possi-
`ble identical for both wavelengths.
`0 Patient insulation
`
`the LED controller output
`For patient protection,
`stage and photodiode input stage were electrically
`‘isolated from the mains using Burr & Brown isola-
`tion amplifiers. These units were powered by an
`insulated power pack.
`Heating
`Sensors incorporating a resistance coil were fitted with
`a precision controller stabilizing temperature within
`the range 38.0—4l.O °C to an accuracy of0.] °C.
`Vacuum pump
`The sensor is fixed to the skin using a small pump
`producing a maximal -300 mbar vacuum. The pump
`
`

`

`Kiiirig H m’: Tire Zurich Ohsre.':'ir Re_fle(ram'e' Pulse O.\‘i1m.'n:I'
`
`-NJ‘)
`
`start: 23. 1.97 9:19:21
`npoxu.
`Lxxxxxxx Rx:-oc gab. 20.03.63 US Daturl
`
`'
`
`-
`
`'
`
`0 sec File: L903!-923-PX2
`
`FE“
`--
`
`W—
`
`_
`——
`
`-131
`
`———_
`
`Marker:
`
`Fig. 3. Srm-n display qf :1 I0-minute h‘l£’d'$HI"t’li'h‘.'l"l'f. From top to banom: oxygen saturation, heart rare, hear: mrefram HP CTG mauirnr,
`uterine roirrracriorifiuiii HP CTC mcmflor. Undermmrh the DC and AC sigrrals for infrared am} red ligirrfur the his! 5 secomis (mm the
`dnflereiwt o.rriinare scaicsfor DC and AC).
`
`is maintained electronically via a manometer at a
`preset negative pressure. ln normal medical use, ad-
`equate fixation is achieved with a vacuum of about
`—l00 mbar.
`
`Sofiware
`
`Apart from various test programs, a program for data
`acquisition, display, calculation and storage and a pro—
`gram for subsequent data postprocessing were written
`in PASCAL.
`
`0 Signal acquisition, calculation and display
`For data acquisition a 486 DOS computer was
`equipped with a 12-bit analogfdigital conversion
`
`(ADC) card (Mctrabyte). A counter on this ca1'd
`triggers analogjdigital conversion at 400 Hz, which
`.starts an interrupt program in the computer for read-
`ing the 4 measured values DC,“ DC,,_.,; and AC,“
`AC,,.,g into a cyclic buffer of 5-second length. From
`the signal (AC,,.+AC,cd} the rnaxirna and minima are
`determined for each cardiac cycle, and hence the
`instantaneous heart rate. Oxygen saturations are cal-
`culated from the amplitudes ac and dc of the AC and
`DC signals.
`Saturation is calculated from the Lambert-Beer
`law using the absorption coefficients [11]
`for
`the
`nominal wavelengths of our LEDs. However, as
`the actual wavelengths may deviate from these nom-
`inal values and the applicability of the Lambert—Beer
`law is limited by scattering in tissue, experimental
`
`

`

`410 _[orrr.Iim"qfClr'nicaI A/Ioirfroring rmri CompHH'n_g V0314 No 6 x1HgI:sr1998
`
`calibration of the measured saturation values is essen-
`tial.
`
`CalflJr'ation
`
`Saturation and heart rate can be averaged over 1-9
`cardiac cycles and are displayed every second. Analog
`hea1't rate and uterine contraction signals from any
`CTG monitor with analog output
`(e.g. Hewlett
`Packard model 8040) can be input to the ADC every
`second and likewise displayed.
`The measurement display (Figure 3) shows, along the
`bottom, the 4 measured values DC;,, DCM and AC;,.,
`AC,cd, over the last 5 seconds of measurement. This
`serves to monitor signal quality during acquisition.
`Poor—signal periods can be marked and excluded from
`data processing. Along the top, measured arterial
`oxygen saturation and heart rate values per second are
`displayed cyclically over a 10-minute interval, with
`the CTG heart rate and contraction input under-
`neath. Any time point can be marked for subsequent
`identification and all values and comment stored in a
`
`file at any time.
`0 Data analysis
`The values from a stored file can be redisplayed in
`measurement mode using an evaluation program.
`Time intervals can be marked with the arrow keys or
`mouse. Means and standard deviations — including
`the CTG data — are then calculated and displayed.
`
`MEASUREMENTS Mil IIISIIIJSSIIIH
`
`Clinical application ofany new instrument or measure-
`ment system presumes:
`
`— mechanical reliability, accuracy and calibration,
`— feasibility in the clinical situation, including accept-
`ance by both medical personnel and patients,
`— the ability not only to determine physiological pa-
`rameters not previously measured in both physiolog-
`ical and pathological situations, but also to evaluate
`the diagnostic significance of such parameters, in this
`case oxygen saturation.
`For the first two more technical points is to say, that
`our instrument required calibration before clinical
`use, together with field tests ofthe suction device and
`long—term oximeter performance during birth.
`For
`these points controls and clinical
`trials were
`performed in our own unit and with colleagues in
`Copenhagen (DK), Graz (A), Oulu (SF) and Berlin
`(D). The major investigations comprised:
`
`To calibrate a pulse oximetcr, an oxygen saturation
`value must be assigned to the measured variables
`
`R = rm]/rir = [ac[dc)m.]/(ac/dc)“,
`
`cf (7)
`
`on the basis of an experimental or theoretical relation-
`ship. Initially we used the absorption coefficients of
`Zijlstra er al [11]. The general problems of calibrating a
`pulse oximeter have been discussed elsewhere [12, 13].
`For fine calibration we performed the following inves-
`tigations:
`
`0 Tests in the arterial oxygen saturation range 88-
`100% were conducted in 14 healthy adult volunteers
`breathing normal air and then air with approxi—'
`mately 80% normal oxygen content for 10 minutes
`in each case. The reflection sensor was fixed to the
`
`forehead or sternum with an adhesive ring. Owing to
`the invasive nature of arterial cathcterization, refer-
`
`ence values were provided by a MINOLTA PUL-
`SOX 8 transmission pulse oximeter attached to the
`index finger. Data analysis [13] showed a 4.5% differ-
`ence in oxygen saturation between the MINOLTA
`and the preliminary results of our reflectance system
`based on the absorption coefiicents ofZijlstra et al.
`0 At lower saturation levels, measurements were per-
`formed in cyanotic children before surgery. The chil-
`dren had arterial lines, permitting direct comparison
`with arterial blood readings [14].
`0 Low saturations in viva can also be measured in the
`
`fetal lamb [15]. We used this method to compare our
`pulse oximeter readings directly with arterial values
`in the oxygen saturation range 10-80% [16].
`
`Preliminary evaluation of these data shows that our
`previous calculations of oxygen saturation have to be
`corrected in the 1[}—10()% saturation range by a factor of
`1.045.
`
`Fixa than
`
`The first experiments in sensor fixation to the head and
`other parts of the human body were performed in
`adults [17] and neonates [18].
`Attachment is simple in practice, even during birth.
`After rupture of the membranes, the sensor can be fixed
`to the fetal head once the cervix has dilated to at least 2
`cm. Initial fixation takes 30-60 seconds and allows full
`
`freedom ofmovement [19].
`Approximately 100 mbar is the most suitable pressure
`
`

`

`at which to

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket